NDC 63629-4556

NP Thyroid 30

Levothyroxine, Liothyronine

NP Thyroid 30 is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Bryant Ranch Prepack. The primary component is Levothyroxine; Liothyronine.

Product ID63629-4556_1f6bb532-2495-4fc7-ae0b-fed0858a4796
NDC63629-4556
Product TypeHuman Prescription Drug
Proprietary NameNP Thyroid 30
Generic NameLevothyroxine, Liothyronine
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2011-01-14
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameBryant Ranch Prepack
Substance NameLEVOTHYROXINE; LIOTHYRONINE
Active Ingredient Strength19 ug/1; ug/1
Pharm Classesl-Thyroxine [EPC],Thyroxine [CS],l-Triiodothyronine [EPC],Triiodothyronine [CS]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 63629-4556-1

30 TABLET in 1 BOTTLE (63629-4556-1)
Marketing Start Date2011-08-19
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 63629-4556-3 [63629455603]

NP Thyroid 30 TABLET
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-08-19
Inactivation Date2020-01-31

NDC 63629-4556-1 [63629455601]

NP Thyroid 30 TABLET
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-08-19
Inactivation Date2020-01-31

NDC 63629-4556-2 [63629455602]

NP Thyroid 30 TABLET
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-08-19
Inactivation Date2020-01-31

NDC 63629-4556-5 [63629455605]

NP Thyroid 30 TABLET
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-08-19
Inactivation Date2020-01-31

NDC 63629-4556-4 [63629455604]

NP Thyroid 30 TABLET
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-08-19
Inactivation Date2020-01-31

NDC 63629-4556-6 [63629455606]

NP Thyroid 30 TABLET
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-08-19
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
LEVOTHYROXINE19 ug/1

OpenFDA Data

SPL SET ID:d3ce9a73-5f3a-4c1b-a4b7-06f45316d61a
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 313387
  • 1724439
  • Pharmacological Class

    • l-Thyroxine [EPC]
    • Thyroxine [CS]
    • l-Triiodothyronine [EPC]
    • Triiodothyronine [CS]

    NDC Crossover Matching brand name "NP Thyroid 30" or generic name "Levothyroxine, Liothyronine"

    NDCBrand NameGeneric Name
    42192-329NP Thyroid 30LEVOTHYROXINE, LIOTHYRONINE
    50090-4376NP Thyroid 30LEVOTHYROXINE, LIOTHYRONINE
    53002-1119NP Thyroid 30LEVOTHYROXINE, LIOTHYRONINE
    63629-4556NP Thyroid 30LEVOTHYROXINE, LIOTHYRONINE
    68788-7031NP Thyroid 30LEVOTHYROXINE, LIOTHYRONINE
    68788-8290NP Thyroid 30LEVOTHYROXINE, LIOTHYRONINE
    70934-333NP Thyroid 30LEVOTHYROXINE, LIOTHYRONINE
    72189-218NP THYROIDlevothyroxine, liothyronine
    42192-328NP Thyroid 120LEVOTHYROXINE, LIOTHYRONINE
    68788-7034NP Thyroid 120LEVOTHYROXINE, LIOTHYRONINE
    42192-327NP Thyroid 15LEVOTHYROXINE, LIOTHYRONINE
    63629-8265NP Thyroid 15LEVOTHYROXINE, LIOTHYRONINE
    68788-7030NP Thyroid 15LEVOTHYROXINE, LIOTHYRONINE
    68788-8289NP Thyroid 15LEVOTHYROXINE, LIOTHYRONINE
    42192-330NP Thyroid 60LEVOTHYROXINE, LIOTHYRONINE
    45865-566NP Thyroid 60LEVOTHYROXINE, LIOTHYRONINE
    50090-5216NP Thyroid 60LEVOTHYROXINE, LIOTHYRONINE
    53002-1029NP Thyroid 60LEVOTHYROXINE, LIOTHYRONINE
    68788-7032NP Thyroid 60LEVOTHYROXINE, LIOTHYRONINE
    70934-806NP Thyroid 60LEVOTHYROXINE, LIOTHYRONINE
    71335-0414NP Thyroid 60LEVOTHYROXINE, LIOTHYRONINE
    42192-331NP Thyroid 90LEVOTHYROXINE, LIOTHYRONINE
    50090-5229NP Thyroid 90LEVOTHYROXINE, LIOTHYRONINE
    53002-5800NP Thyroid 90LEVOTHYROXINE, LIOTHYRONINE
    63629-8266NP Thyroid 90LEVOTHYROXINE, LIOTHYRONINE
    68788-7033NP Thyroid 90LEVOTHYROXINE, LIOTHYRONINE

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.